Ingevity Corp buy BMO Capital Markets
Start price
05.09.25
/
50%
€51.00
Target price
05.09.26
€58.30
Performance (%)
-4.39%
Price
07:34
?
Summary
This prediction is currently active. With a performance of -4.39%, the BUY prediction by BMO_Capital_Markets is trending in the wrong direction. This prediction currently runs until 05.09.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ingevity Corp | -1.048% | -1.048% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by BMO_Capital_Markets for this prediction
In the thread Ingevity Corp diskutieren
Ingevity (NYSE:NGVT) had its price target raised by analysts at BMO Capital Markets from $62.00 to $68.00. They now have an "outperform" rating on the stock.
Ratings data for NGVT provided by MarketBeat